CMR Surgical, the company that produces and sells the CMR Surgical Robot, was founded in 2014 and is based in Cambridge, UK. The company was co-founded by Martin Frost and Luke Hares, who are both experienced entrepreneurs in the medical technology field.
Since its founding, CMR Surgical has raised significant funding to support the development and commercialization of the CMR Surgical Robot. In 2019, the company raised $240 million in a funding round led by SoftBank Vision Fund, which valued the company at $1.2 billion.
As of my knowledge cutoff in 2021, CMR Surgical was a privately held company, which means that its ownership is not publicly disclosed. However, the company has a number of investors, including venture capital firms, private equity firms, and strategic investors in the medical technology industry.
The CMR Surgical Robot is a medical device used in surgical procedures. It is a robotic system designed to assist surgeons in performing minimally invasive procedures, such as laparoscopic surgeries. The system consists of a console, a set of robotic arms, and a 3D high-definition vision system.
The console is where the surgeon sits and controls the robotic arms using hand controllers and foot pedals. The robotic arms, which are equipped with surgical instruments, are inserted into the patient's body through small incisions. The 3D high-definition vision system provides the surgeon with a clear and detailed view of the surgical site.
The CMR Surgical Robot is designed to be compact, lightweight, and portable, making it easy to move between operating rooms. It is also designed to be user-friendly, with intuitive controls and a simple interface that allows surgeons to quickly learn how to use the system.
The use of robotic systems like the CMR Surgical Robot has several benefits for patients, including smaller incisions, less pain and scarring, shorter hospital stays, and faster recovery times. Additionally, the use of robotic systems allows surgeons to perform more precise and accurate procedures, reducing the risk of complications and improving patient outcomes.
Supratim joined the Company in February 2023 as a senior advisor to the CEO, taking over the leadership of Asia, Middle East, and Africa regions, leading commercial operations across the three regions.
Supratim joins CMR with more than 40 years of extensive senior leadership experience in the medical technology industry. He has held several leadership positions in global organizations, including Johnson & Johnson (J&J), Boston Scientific, and ConvaTec. Supratim takes up the appointment as the Company further commercializes the business, with more than 100 Versius systems installed globally.
With extensive MedTech leadership experience, Supratim will now step into the role of CEO, overseeing the Company’s global rollout of the Versius® Surgical Robotic System.
Umur Hursever, on behalf of the Board of CMR Surgical, commented: “We are delighted to have someone of Supratim’s experience leading CMR. CMR has a very powerful mission to bring minimal access surgery to everyone who needs it, and given Supratim’s exceptional track record leading global MedTech businesses I am excited to work with him and the leadership team to continue to disrupt the market. I would like to thank Per Vegard for his contributions to CMR and wish him well for the future.”
Supratim Bose, Chief Executive Officer of CMR Surgical, said: “With Versius we have an opportunity to help hospitals and surgeons transform surgery for people around the world. I am excited to lead a business that has such a differentiated product with Versius, that is addressing a high unmet need for better surgical care around the world. I look forward to working with everyone at CMR to bring the benefits of surgical robotics to hospitals and surgeons around the world.”
Per Vegard Nerseth said: “During my time at the Company I am proud to have seen CMR expand its commercial operations and bring Versius into the hands of more surgeons and hospitals. After experiencing strong growth, CMR is now the second-largest surgical robotics company on the market with a significant presence across four continents. I look forward to seeing the Company continue to grow so that more hospitals and patients can benefit from minimal access surgery.”
CMR now has operations in more than 20 markets with growing demand for a versatile surgical robotic system. Versius is the only small, versatile, modular, and portable surgical robot on the market and is suitable for all sizes of hospitals and surgical care centers. The system allows surgeons the versatility to perform fully robotic as well as a combination of robotic and manual laparoscopic procedures, giving them the freedom to decide how to provide patients with the best possible surgical care.